Sterile Fill Finish

  • Sterile Fill Finish 1
  • Sterile Fill Finish 2
  • Sterile Fill Finish 3
Product Description

Eramol specialises in early-phase sterile fill-finish, including aseptic processing, terminal sterilisation, sterile vial manufacturing, clinical packaging, UK & EU QP release and clinical trial supply.

Aseptic and Terminal sterilisation small molecule large molecule/biologics ADCs ATMPS Cell & Gene Therapy Peptides Oligonucleotides Radiopharma Viral Vectors

https://eramol.com/clinical-services/sterile-manufacturing/aseptic/

https://eramol.com/clinical-services/sterile-manufacturing/terminal-sterilisation/

https://eramol.com/clinical-services-category/non-sterile-manufacturing/

https://eramol.com/why-low-line-losses-matter-in-early-phase-sterile-fill-finish/

https://eramol.com/sevenoaks-sterile/

Read more Show less

Eramol

  • Country/Region:
    United Kingdom
  • Founded:
    2013
  • On CPHI since:
    2026
  • Certificates:
    4
  • Employees:
    25 - 49
Company types
CMO/CDMO
Primary activities
Contract Manufacturer
View company profile
Categories
more categories Show less
Specifications
  • Details
    Eramol specialises in early-phase sterile fill-finish, including aseptic processing, terminal sterilisation, sterile vial manufacturing, clinical packaging, UK & EU QP release and clinical trial supply.

    Aseptic and Terminal sterilisation

    small molecule
    large molecule/biologics
    ADCs
    ATMPS
    Cell & Gene Therapy
    Peptides
    Oligonucleotides
    Radiopharma
    Viral Vectors

    https://eramol.com/clinical-services/sterile-fill-finish/end-to-end-early-phase-sterile-fill-finis...
  • Selling Points
    End to End clinical manufacturing

    Manufacture, packaging, labelling, QC testing, QP Release, storage & global distribution capabilities 

    https://eramol.com/about/client-centric-end-to-end-approach/
More specifications Fewer specifications

Eramol

  • Country/Region:
    United Kingdom
  • Founded:
    2013
  • On CPHI since:
    2026
  • Certificates:
    4
  • Employees:
    25 - 49
Company types
CMO/CDMO
Primary activities
Contract Manufacturer
View company profile

More Products from Eramol (4)

  • Non Sterile Manufacturing

    Product Non Sterile Manufacturing

    Oral dosage forms (tablets, capsules, oral liquids)Actives and placebos
  • Packaging & Labelling

    Product Packaging & Labelling

    Primary and Secondary packaging and labelling capabilities 

    https://eramol.com/clinical-services-category/clinical-packaging/

    https://eramol.com/clinical-services-category/labelling-solutions/
  • QP Release

    Product QP Release

    QP Release into UK & EU market

    https://eramol.com/clinical-services-category/eu-uk-qp-release/
  • Storage & Distribution

    Product Storage & Distribution

    Storage and global distribution capabilities 

    https://eramol.com/clinical-services-category/clinical-storage-distribution/

Eramol resources (1)

  • New Sterile Manufacturing Facility (End to End CMO service)

    News New Sterile Manufacturing Facility (End to End CMO service)

    Eramol’s new sterile manufacturing facility at its Sevenoaks campus is a purpose-built, EU GMP Annex 1 aligned site designed to support early-phase sterile injectable programmes. The facility features isolator-based aseptic fill-finish and terminal sterilisation, with phase-appropriate batch sizes and a strong focus on sterility assurance and product protection, achieving <1% line losses. Fully integrated with Eramol’s wider services, the facility provides an end-to-end sterile solution including packaging and labelling, QC testing, UK/EU QP release, regulatory support, GMP/GDP storage and global distribution, with planned expansion to support later-stage and commercial manufacturing.
    22 Jan 2026